Congqing Pan

Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease

Yonghui Hu, Wangna Tang, Wenjie Liu et al. · Drug Design Development and Therapy · 2022 · 39 citations · Full text

Life Sciences, Cell Biology, Pathobiology +16

Association of Thyroid Hormone Levels with Microvascular Complications in Euthyroid Type 2 Diabetes Mellitus Patients

Yonghui Hu, Zhibo Hu, Wangna Tang et al. · Diabetes Metabolic Syndrome and Obesity · 2022 · 26 citations · Full text

Medicine, Endocrinology, Internal Medicine +16

Complement C7 is Specifically Expressed in Mesangial Cells and is a Potential Diagnostic Biomarker for Diabetic Nephropathy and is Regulated by miR-494-3p and miR-574-5p

Hang Guo, Zhiyue Yan, Yonghui Hu et al. · Diabetes Metabolic Syndrome and Obesity · 2021 · 24 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +17

Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients

Yonghui Hu, Zhiyue Yan, Congqing Pan · Diabetes Metabolic Syndrome and Obesity · 2021 · 13 citations · Full text

Medicine, Endocrinology, Internal Medicine +13

Astragaloside IV attenuates podocyte apoptosis via regulating TXNIP/NLRP3/GSDMD signaling pathway in diabetic nephropathy

Zhibo Hu, Yu Zhou, Junfen Liu et al. · Diabetology & Metabolic Syndrome · 2024 · 11 citations · Full text

Medicine, Pathology, Pharmacology +17